Asia-Pacific Veterinary Vaccines Market By Type (Livestock Vaccines And Companion Vaccines), By Technology (live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, Toxoid Vaccines, Subunit Vaccines, DNA Vaccines And Conjugate Vaccines) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts 2018-2023
Asia-Pacific Veterinary Vaccines Market By Type (Livestock Vaccines And Companion Vaccines), By Technology (live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, Toxoid Vaccines, Subunit Vaccines, DNA Vaccines And Conjugate Vaccines) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts 2018-2023
ID: 82 | Pages: 135 | October 2018 | Region: Asia Pacific
The Asia-Pacific animal vaccines market is poised to reach USD 1.53 Billion by 2023 from USD 1.08 Billion in 2018, at a CAGR of 7.22% from 2018-2023. It has seen significant growth over the past few years, due to fear of imminent epidemics that have led to substantial losses particularly in poultry segment. Veterinary vaccine market’s substantial growth can be attributed to increasing husbandry practices and better management of farms. This marks the estimation of further growth in the market due to advancement in biotechnological research.
Large breeding companies, out of overall consideration based on economic benefits, are increasingly inclined to buy high-quality market-oriented vaccines which are 5-15 times as expensive as vaccines purchased under policy. Local animal vaccine companies are also scaling up efforts for research and development, making their presence in high-end vaccines and expanding varieties of vaccines. There were 25 kinds of registered animal vaccines in China in 2015, including 10 kinds of pig vaccines, 10 kinds of poultry vaccines, and 5 kinds of other animal vaccines. Moreover, great progress has been made in pet vaccines. On a major note, Rabies vaccines are expected to be approved and go on the market at the end of 2016 or in 2017. On other hand rapid industrialization of the entire livestock segment, an impending shift to internationally acclaimed practices; increased realization among progressive farmers about disease management and prevention and more animal diseases being taken up by federal as well as state governments for mass vaccination programs are increasing the market in India. However, rising maintenance costs for the storage of vaccines, increasing adoption of vegetarian diet in major economies owing to risk of obesity and other chronic diseases are key restraints of the market in this region.
The Asia-Pacific veterinary vaccines market has been categorized as livestock and companion vaccines. Further, the livestock vaccines segment has been segmented into five categories namely, bovine, porcine, ovine, poultry and equine. The companion animal vaccines segment has also been further categorized into feline and canine vaccines. In addition, based on production technologies the market is segmented as live attenuated vaccines, inactivated vaccines, recombinant vaccines, toxoid vaccines, subunit vaccines, DNA vaccines and conjugate vaccines. The canine vaccines segment accounted for a slightly larger share (in terms of revenue) than the feline vaccines segment, due to higher average cost allied with canine vaccination. Similarly, the bovine vaccines sub-segment accounted for the largest share (in terms of revenue), followed by porcine. Furthermore, on the basis of geography, the Asia-Pacific Market is analysed under various regions namely, India, China, Japan and South Korea.
Some of the key players influencing the market are Bayer HealthCare AG, Bioniche Animal Health Canada, Sanofi Animal Health, Inc., Biogenesis Bago SA, Heska Corporation, Indian Immunologicals Ltd., Boehringer Ingelheim GmbH, Zoetis, Novartis Animal Heath, Inc., Merck & Co. Inc, and Protein Sciences.
- Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
- Research Methodology
2.1 Introduction
2.2 Analysis Design
2.3 Research Phases
2.3.1 Secondary Research
2.3.2 Primary Research
2.3.3 Econometric Modelling
2.3.4 Expert Validation
2.4 Study Timeline
- Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
- Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
- Market Segmentation
5.1 By Type
5.1.1 Livestock vaccines
5.1.1.1 Bovine
5.1.1.2 Porcine
5.1.1.3 Ovine
5.1.1.4 Poultry
5.1.1.5 Equine
5.1.2 Companion vaccines
5.1.2.1 Canine
5.1.2.2 Feline
5.2 Technology
5.2.1 Live attenuated vaccines
5.2.2 Inactivated vaccines
5.2.3 Recombinant vaccines
5.2.4 Toxoid vaccines
5.2.5 Subunit vaccines
5.2.6 DNA vaccines
5.2.7 Conjugate vaccines
- Geographical Analysis
6.1 Introduction
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
- Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
- Market Leaders' Analysis
8.1 Bayer Healthcare AG
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Bioniche Animal Health Canada
8.3 Sanofi Animal Health Inc.
8.4 Biogenesis Bago SA
8.5 Heska Corporation
8.6 Indian Immunologicals Ltd.
8.7 Boehringer Ingelheim GmbH
8.8 Novartis Animal Health, Inc.
8.9 Merck & Co. Inc.
8.10 Protein Sciences
- Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
- Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
- List of Tables
- List of Figures
- Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
- Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
- Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
- Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
- Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
- A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
- Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
- An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
- Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
| Title | Price | Add To Cart |
- Asia-Pacific Veterinary Vaccines Market By Region, From 2018-2023 ( USD Billion )
- Asia-Pacific Veterinary Vaccines Market By Type, From 2018-2023 ( USD Billion )
- Asia-Pacific Livestock vaccines Market By Region, From 2018-2023 ( USD Billion )
- Asia-Pacific Companion vaccines Market By Region, From 2018-2023 ( USD Billion )
- Asia-Pacific Veterinary Vaccines Market By Technology, From 2018-2023 ( USD Billion )
- Asia-Pacific Live attenuated vaccines Market By Region, From 2018-2023 ( USD Billion )
- Asia-Pacific Inactivated vaccines Market By Region, From 2018-2023 ( USD Billion )
- Asia-Pacific Recombinant vaccines Market By Region, From 2018-2023 ( USD Billion )
- Asia-Pacific Toxoid vaccines Market By Region, From 2018-2023 ( USD Billion )
- Asia-Pacific Subunit vaccines Market By Region, From 2018-2023 ( USD Billion )
- Asia-Pacific DNA vaccines Market By Region, From 2018-2023 ( USD Billion )
- Asia-Pacific Conjugate vaccines Market By Region, From 2018-2023 ( USD Billion )
- Asia-Pacific Livestock Vaccines Market By Type, From 2018-2023 ( USD Billion )
- Asia-Pacific Bovine Market By Region, From 2018-2023 ( USD Billion )
- Asia-Pacific porcine Market By Region, From 2018-2023 ( USD Billion )
- Asia-Pacific Ovine Market By Region, From 2018-2023 ( USD Billion )
- Asia-Pacific Poultry Market By Region, From 2018-2023 ( USD Billion )
- Asia-Pacific Equine Market By Region, From 2018-2023 ( USD Billion )
- Asia-Pacific Companion Animal Vaccines Market By Type, From 2018-2023 ( USD Billion )
- Asia-Pacific canine Market By Region, From 2018-2023 ( USD Billion )
- Asia-Pacific feline Market By Region, From 2018-2023 ( USD Billion )
- China Veterinary Vaccines Market By Type, From 2018-2023 ( USD Billion )
- China Veterinary Vaccines Market By Technology, From 2018-2023 ( USD Billion )
- India Veterinary Vaccines Market By Type, From 2018-2023 ( USD Billion )
- India Veterinary Vaccines Market By Technology, From 2018-2023 ( USD Billion )
- Japan Veterinary Vaccines Market By Type, From 2018-2023 ( USD Billion )
- Japan Veterinary Vaccines Market By Technology, From 2018-2023 ( USD Billion )
- South Korea Veterinary Vaccines Market By Type, From 2018-2023 ( USD Billion )
- South Korea Veterinary Vaccines Market By Technology, From 2018-2023 ( USD Billion )
- China Livestock Vaccines Market By Type, From 2018-2023 ( USD Billion )
- India Livestock Vaccines Market By Type, From 2018-2023 ( USD Billion )
- Japan Livestock Vaccines Market By Type, From 2018-2023 ( USD Billion )
- South Korea Livestock Vaccines Market By Type, From 2018-2023 ( USD Billion )
- China Companion Animal Vaccines Market By Type, From 2018-2023 ( USD Billion )
- India Companion Animal Vaccines Market By Type, From 2018-2023 ( USD Billion )
- Japan Companion Animal Vaccines Market By Type, From 2018-2023 ( USD Billion )
- South Korea Companion Animal Vaccines Market By Type, From 2018-2023 ( USD Billion )
Licence Type 
Clients
Why buy reports from Market Data Forecast
Free Customization
Free report customization that helps you gain required information for always being one step ahead of the competition
Post Purchase Support
6 months of post purchase support via email and phone; serving your needs 24x7 and helping you troubleshoot any technical issues
Best Price guaranteed
Customer focused research services and expertly devised strategic analyses made into premium quality reports at lowest prices
Insightful Snapshots
Summarized overviews of entire reports into customized presentations to ascertain market estimations and driving forces at a quick glance